These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36988110)

  • 1. Effects of 2 and 3 Vaccinations With the Bivalent Human Papillomavirus (HPV) Vaccine on the Prevalence and Load of HPV in Clearing and Persistent Infections in Young Women.
    van Eer K; Middeldorp M; Dzebisasjvili T; Lamkaraf N; de Melker HE; Steenbergen RDM; King AJ
    J Infect Dis; 2023 Oct; 228(8):1012-1022. PubMed ID: 36988110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    van der Weele P; Breeuwsma M; Donken R; van Logchem E; van Marm-Wattimena N; de Melker H; Meijer CJLM; King AJ
    PLoS One; 2019; 14(3):e0212927. PubMed ID: 30830913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women.
    Donken R; King AJ; Bogaards JA; Woestenberg PJ; Meijer CJLM; de Melker HE
    J Infect Dis; 2018 Apr; 217(10):1579-1589. PubMed ID: 29409034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
    Woestenberg PJ; King AJ; van Benthem BHB; Donken R; Leussink S; van der Klis FRM; de Melker HE; van der Sande MAB; Hoebe CJPA; Bogaards JA;
    J Infect Dis; 2018 Jan; 217(2):213-222. PubMed ID: 29140439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule.
    Hoes J; King AJ; Klooster TMSV; Berkhof J; Bogaards JA; de Melker HE
    J Infect Dis; 2022 Sep; 226(4):634-643. PubMed ID: 33964158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
    Kumakech E; Berggren V; Wabinga H; Lillsunde-Larsson G; Helenius G; Kaliff M; Karlsson M; Kirimunda S; Musubika C; Andersson S
    PLoS One; 2016; 11(8):e0160099. PubMed ID: 27482705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination.
    van Eer K; Laâbi I; van Benthem BHB; Steenbergen RDM; King AJ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Tumour Virus Res; 2022 Jun; 13():200233. PubMed ID: 34958987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
    Hoes J; Woestenberg PJ; Bogaards JA; King AJ; de Melker HE; Berkhof J; Hoebe CJPA; van der Sande MAB; van Benthem BHB;
    Clin Infect Dis; 2021 Mar; 72(5):e103-e111. PubMed ID: 33249475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Common Vaginal Infections and Cervical Non-Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women.
    Hu SY; Tsang SH; Chen F; Pan QJ; Zhang WH; Hong Y; Sampson JN; Hildesheim A; Zhao FH; Kreimer AR
    J Infect Dis; 2021 Feb; 223(3):445-451. PubMed ID: 32614401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.
    Lehtinen T; Söderlund-Strand A; Petäjä T; Eriksson T; Jokiranta S; Natunen K; Dillner J; Lehtinen M
    J Infect Dis; 2017 Nov; 216(8):966-968. PubMed ID: 28968844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
    Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study.
    Loenenbach A; Schönfeld V; Takla A; Wiese-Posselt M; Marquis A; Thies S; Sand M; Kaufmann AM; Wichmann O; Harder T
    Front Public Health; 2023; 11():1204101. PubMed ID: 37719724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).
    Guo F; Hirth JM; Berenson AB
    Hum Vaccin Immunother; 2015; 11(10):2337-44. PubMed ID: 26376014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
    Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
    Porras C; Sampson JN; Herrero R; Gail MH; Cortés B; Hildesheim A; Cyr J; Romero B; Schiller JT; Montero C; Pinto LA; Schussler J; Coronado K; Sierra MS; Kim JJ; Torres CM; Carvajal L; Wagner S; Campos NG; Ocampo R; Kemp TJ; Zuniga M; Lowy DR; Avila C; Chanock S; Castrillo A; Estrada Y; Barrientos G; Monge C; Oconitrillo MY; Kreimer AR
    Vaccine; 2022 Jan; 40(1):76-88. PubMed ID: 34857420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
    Struyf F; Colau B; Wheeler CM; Naud P; Garland S; Quint W; Chow SN; Salmerón J; Lehtinen M; Del Rosario-Raymundo MR; Paavonen J; Teixeira JC; Germar MJ; Peters K; Skinner SR; Limson G; Castellsagué X; Poppe WA; Ramjattan B; Klein TD; Schwarz TF; Chatterjee A; Tjalma WA; Diaz-Mitoma F; Lewis DJ; Harper DM; Molijn A; van Doorn LJ; David MP; Dubin G;
    Clin Vaccine Immunol; 2015 Feb; 22(2):235-44. PubMed ID: 25540273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women.
    Feder MA; Kulasingam SL; Kiviat NB; Mao C; Nelson EJ; Winer RL; Whitham HK; Lin J; Hawes SE
    J Womens Health (Larchmt); 2019 Oct; 28(10):1428-1435. PubMed ID: 31264912
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era.
    Kitamura T; Suzuki M; Shigehara K; Fukuda K; Matsuyama T; Kume H
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.